2014
DOI: 10.1159/000358264
|View full text |Cite
|
Sign up to set email alerts
|

Fine-Needle Aspiration Cytology of Thyroid Nodules with Hürthle Cells: Cytomorphologic Predictors for Neoplasms, Improving Diagnostic Accuracy and Overcoming Pitfalls

Abstract: Objectives: Hürthle cells (HCs) are follicular-derived oncocytic cells seen in a variety of neoplastic and nonneoplastic pathologic entities of the thyroid gland. This study was to report our experience of the surgical outcome on the finding of HCs on fine-needle aspiration biopsies (FNABs) of thyroid nodules, to identify cytologic predictors of HC neoplasms and an attempt to overcome diagnostic pitfalls. Study Design: This was a retrospective study of all FNAB of thyroid nodules with findings of HCs with subs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 16 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Many cytologic features have been proposed for distinguishing nonneoplastic Hürthle cell nodules from neoplastic nodules as well as benign from malignant nodules, although to the best of our knowledge no criteria have been widely accepted. These include cellularity, [2][3][4][5] the amount of colloid, [2][3][4][6][7][8] architecture (ie, macrofollicular sheets, crowded groups, singly dispersed cells), 3,5,7,8 and nuclear pleomorphism or "dysplasia," 2,3,[5][6][7][8][9] among others. Given the inconsistency of cytologic features in the evaluation of HC FNA, it also has been suggested in The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) that clinicopathologic correlation can aid in evaluation.…”
Section: Introductionmentioning
confidence: 99%
“…Many cytologic features have been proposed for distinguishing nonneoplastic Hürthle cell nodules from neoplastic nodules as well as benign from malignant nodules, although to the best of our knowledge no criteria have been widely accepted. These include cellularity, [2][3][4][5] the amount of colloid, [2][3][4][6][7][8] architecture (ie, macrofollicular sheets, crowded groups, singly dispersed cells), 3,5,7,8 and nuclear pleomorphism or "dysplasia," 2,3,[5][6][7][8][9] among others. Given the inconsistency of cytologic features in the evaluation of HC FNA, it also has been suggested in The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) that clinicopathologic correlation can aid in evaluation.…”
Section: Introductionmentioning
confidence: 99%